晨光生物：2025年第三季度归属于上市公司股东的净利润同比增长338.68%

Core Insights - The company reported a total revenue of 1,389,706,738.86 yuan for the third quarter of 2025, representing a year-on-year decline of 19.88% [1] - The net profit attributable to shareholders of the listed company was 88,857,708.13 yuan, showing a significant year-on-year increase of 338.68% [1] Financial Performance - Revenue for Q3 2025: 1,389,706,738.86 yuan, down 19.88% year-on-year [1] - Net profit for Q3 2025: 88,857,708.13 yuan, up 338.68% year-on-year [1]